{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:48:55Z","timestamp":1770421735740,"version":"3.49.0"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Backgroung:<\/jats:title>\n<jats:p>Fibromyalgia may be associated to Spondyloarthritis with which it shares some common symptoms such as sleep disorders, fatigue and diffuse pain, leading to diagnostic and treatment dilemmas.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>We aimed to determine the prevalence of fibromyalgia in axial spondyloarthritis and to determine how fibromyalgia might influence the assessments of disease activity and how it might impact treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>An observational cross-sectional study was conducted. The study included 100 patients with axial spondyloarthritis according to the Assessment of SpondyloArthritis international Society criteria. Fibromyalgia was diagnosed based on the 2010 American College of Rheumatology crite-ria. Demographics, disease characteristics, activity parameters and treatment were compared be-tween patients with and without fibromyalgia. Patients were recruited from the hospitalization unit and the outpatient clinic of rheumatology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The mean age of patients was 44.65 \u00b1 13.13 years, with a sex ratio equal to 2. The preva-lence of fibromyalgia was 20%. Fibromyalgia associated factors were advanced age and a late age at the onset of axial spondyloarthritis. Disease activity parameters such as global pain VAS, BASDAI, ASDAS-ESR, ASDAS-CRP, BASFI and BAS-G as well as MASES and BASMI were significantly higher in the presence of FM. Doses of paracetamol were significantly higher among FM+ patients. Also, treatment duration of the current anti-TNF alpha agent was significantly shorter among FM+ patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our study showed that fibromyalgia was associated with axial spondyloarthritis in 20% of patients. Its presence was associated with higher disease activity parameters and negative impact on the treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397118666220902100151","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T12:45:26Z","timestamp":1662209126000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease\nActivity and Treatment"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-0393","authenticated-orcid":true,"given":"Selma","family":"Bouden","sequence":"first","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-8018","authenticated-orcid":true,"given":"Saidane","family":"Olfa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriam","family":"Sahli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aicha Ben","family":"Tekaya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Rouached","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tekaya","family":"Rawdha","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Abdelmoula","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4spital Charles-Nicolle, Tunis, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3899\/jrheum.090367","volume":"36","author":"Mease P.","year":"2009","unstructured":"Mease P.; Arnold L.M.; Choy E.H.; Fibromyalgia syndrome module at OMERACT 9: Domain construct. J Rheumatol 2009,36(10),2318-2329","journal-title":"J Rheumatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e0203755","DOI":"10.1371\/journal.pone.0203755","volume":"13","author":"Wolfe F.","year":"2018","unstructured":"Wolfe F.; Walitt B.; Perrot S.; Rasker J.J.; H&#xE4;user W.; Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS One 2018,13(9),e0203755","journal-title":"PLoS One"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"584573","DOI":"10.1155\/2012\/584573","volume":"2012","author":"Yunus M.B.","year":"2012","unstructured":"Yunus M.B.; The prevalence of fibromyalgia in other chronic pain conditions. Pain Res Treat 2012,2012,584573","journal-title":"Pain Res Treat"},{"key":"ref=4","first-page":"1415","volume":"29","author":"Heikkil&#xE4; S.","year":"2002","unstructured":"Heikkil&#xE4; S.; Ronni S.; Kautiainen H.J.; Kauppi M.J.; Functional impairment in spondyloarthropathy and fibromyalgia. J Rheumatol 2002,29(7),1415-1419","journal-title":"J Rheumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jbspin.2017.03.001","volume":"84","author":"Dougados M.","year":"2017","unstructured":"Dougados M.; Perrot S.; Fibromyalgia and central sensitization in chronic inflammatory joint diseases. Joint Bone Spine 2017,84(5),511-513","journal-title":"Joint Bone Spine"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00296-017-3792-4","volume":"37","author":"Salaffi F.","year":"2017","unstructured":"Salaffi F.; Gerardi M.C.; Atzeni F.; The influence of fibromyalgia on achieving remission in patients with long standing rheumatoid arthritis. Rheumatol Int 2017,37(12),2035-2042","journal-title":"Rheumatol Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"Rudwaleit M.","year":"2009","unstructured":"Rudwaleit M.; van der Heijde D.; Landew&#xE9; R.; The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 2009,68(6),777-783","journal-title":"Ann Rheum Dis"},{"key":"ref=8","first-page":"S33","volume":"28","author":"Almod&#xF3;var R","year":"2010","unstructured":"Almod&#xF3;var R; Carmona L; Zarco P; Fibromyalgia in patients with ankylosing spondylitis: Prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 2010,28(6)(63),S33-9","journal-title":"Clin Exp Rheumatol"},{"key":"ref=9","first-page":"2286","volume":"21","author":"Garrett S.","year":"1994","unstructured":"Garrett S.; Jenkinson T.; Kennedy L.G.; Whitelock H.; Gaisford P.; Calin A.; A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index. J Rheumatol 1994,21(12),2286-2291","journal-title":"J Rheumatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"Lukas C.","year":"2009","unstructured":"Lukas C.; Landew&#xE9; R.; Sieper J.; Development of an ASAS endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009,68(1),18-24","journal-title":"Ann Rheum Dis"},{"key":"ref=11","first-page":"2281","volume":"21","author":"Calin A.","year":"1994","unstructured":"Calin A.; Garrett S.; Whitelock H.; A new approach to defining functional ability in ankylosing spondylitis: The development of the bath ankylosing spondylitis functional index. J Rheumatol 1994,21(12),2281-2285","journal-title":"J Rheumatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","volume":"35","author":"Jones S.D.","year":"1996","unstructured":"Jones S.D.; Steiner A.; Garrett S.L.; Calin A.; The bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol 1996,35(1),66-71","journal-title":"Br J Rheumatol"},{"key":"ref=13","first-page":"779","volume":"24","author":"Lequesne M.G.","year":"1997","unstructured":"Lequesne M.G.; The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997,24(4),779-781","journal-title":"J Rheumatol"},{"key":"ref=14","first-page":"1694","volume":"21","author":"Jenkinson T.R.","year":"1994","unstructured":"Jenkinson T.R.; Mallorie P.A.; Whitelock H.C.; Kennedy L.G.; Garrett S.L.; Calin A.; Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 1994,21(9),1694-1698","journal-title":"J Rheumatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"Heuft D.L.","year":"2003","unstructured":"Heuft D.L.; Spoorenberg A.; Tubergen A.; Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003,62(2),127-132","journal-title":"Ann Rheum Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"Creemers M.C.","year":"2005","unstructured":"Creemers M.C.; Franssen M.J.; Hof M.A.; Gribnau F.W.J.; Putte L.B.A.; Riel P.L.C.M.; Assessment of outcome in ankylosing spondylitis: An extended radiographic scoring system. Ann Rheum Dis 2005,64(1),127-129","journal-title":"Ann Rheum Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"Wolfe F.","year":"2011","unstructured":"Wolfe F.; Clauw D.J.; Fitzcharles M.A.; Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011,38(6),1113-1122","journal-title":"J Rheumatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3344\/kjp.2012.25.3.173","volume":"25","author":"Kim S.M.","year":"2012","unstructured":"Kim S.M.; Lee S.H.; Kim H.R.; Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain 2012,25(3),173-182","journal-title":"Korean J Pain"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1590\/S0482-50042010000600005","volume":"50","author":"Azevedo V.F.","year":"2010","unstructured":"Azevedo V.F.; Paiva E.; Felippe L.R.; Moreira R.A.; Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Reumatol 2010,50(6),646-650","journal-title":"Rev Bras Reumatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","volume":"34","author":"Salaffi F.","year":"2014","unstructured":"Salaffi F.; De Angelis R.; Carotti M.; Gutierrez M.; Sarzi P.P.; Atzeni F.; Fibromyalgia in patients with axial spondyloarthritis: Epidemiological profile and effect on measures of disease activity. Rheumatol Int 2014,34(8),1103-1110","journal-title":"Rheumatol Int"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","volume":"34","author":"Haliloglu S.","year":"2014","unstructured":"Haliloglu S.; Carlioglu A.; Akdeniz D.; Karaaslan Y.; Kosar A.; Fibromyalgia in patients with other rheumatic diseases: Prevalence and relationship with disease activity. Rheumatol Int 2014,34(9),1275-1280","journal-title":"Rheumatol Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/ced.12504","volume":"40","author":"Graceffa D.","year":"2015","unstructured":"Graceffa D.; Maiani E.; Sperduti I.; Ceralli F.; Bonifati C.; Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: The experience of an outpatient dermatological clinic for psoriasis. Clin Exp Dermatol 2015,40(2),136-141","journal-title":"Clin Exp Dermatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1136\/annrheumdis-2015-eular.5965","volume":"74","author":"Baraliakos X.","year":"2015","unstructured":"Baraliakos X.; Regel A.; Kiltz U.; Patients with fibromyalgia (FM) do not fulfill classification criteria for axial spondyloarthritis (AXSPA) but patients with axspa may fulfill classification criteria for FM. Ann Rheum Dis 2015,74(2),S80","journal-title":"Ann Rheum Dis"},{"key":"ref=24","first-page":"1","volume":"68","author":"Magrey M.N.","year":"2016","unstructured":"Magrey M.N.; Diomampo S.; Khan M.A.; Do validated tools of disease activity in ankylosing spondylitis measure fibromyalgia pain? Arthritis Rheumatol 2016,68(10),1","journal-title":"Arthritis Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","volume":"18","author":"Bello N.","year":"2016","unstructured":"Bello N.; Etcheto A.; B&#xE9;al C.; Dougados M.; Molt&#xF3; A.; Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther 2016,18,42","journal-title":"Arthritis Res Ther"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3899\/jrheum.160104","volume":"43","author":"Wach J.","year":"2016","unstructured":"Wach J.; Letroublon M.C.; Coury F.; Tebib J.G.; Fibromyalgia in spondyloarthritis: Effect on disease activity assessment in clinical practice. J Rheumatol 2016,43(11),2056-2063","journal-title":"J Rheumatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"Molt&#xF3; A.","year":"2018","unstructured":"Molt&#xF3; A.; Etcheto A.; Gossec L.; Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: Results of a prospective, multicentre study. Ann Rheum Dis 2018,77(4),533-540","journal-title":"Ann Rheum Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","volume":"47","author":"Fan A.","year":"2017","unstructured":"Fan A.; Pereira B.; Tournadre A.; Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients. Semin Arthritis Rheum 2017,47(1),129-132","journal-title":"Semin Arthritis Rheum"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"Macfarlane G.J.","year":"2017","unstructured":"Macfarlane G.J.; Barnish M.S.; Pathan E.; Co occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: Results from a UK national register. Arthritis Rheumatol 2017,69(11),2144-2150","journal-title":"Arthritis Rheumatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4103\/0975-2870.128977","volume":"7","author":"Amiri A.","year":"2014","unstructured":"Amiri A.; Sedighi O.; Prevalence of fibromyalgia in patients with ankylosing spondylitis. Med J DY Patil Univ 2014,7(3),338-341","journal-title":"Med J DY Patil Univ"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","volume":"57","author":"Baraliakos X.","year":"2018","unstructured":"Baraliakos X.; Regel A.; Kiltz U.; Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford) 2018,57(9),1541-1547","journal-title":"Rheumatology (Oxford)"},{"key":"ref=32","first-page":"E579","volume":"22","author":"Ren&#xE7;ber N.","year":"2019","unstructured":"Ren&#xE7;ber N.; Saglam G.; H&#xFC;ner B.; Kuru O.; Presence of fibromyalgia syndrome and its relationship with clinical parameters in patients with axial spondyloarthritis. Pain Physician 2019,22(6),E579-E585","journal-title":"Pain Physician"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/rheumatology\/kew244","volume":"55","author":"Fan A.","year":"2016","unstructured":"Fan A.; Tournadre A.; Pereira B.; Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases. Rheumatology (Oxford) 2016,55(10),1746-1750","journal-title":"Rheumatology (Oxford)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3899\/jrheum.151491","volume":"43","author":"Brikman S.","year":"2016","unstructured":"Brikman S.; Furer V.; Wollman J.; The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: A cross-sectional study. J Rheumatol 2016,43(9),1749-1754","journal-title":"J Rheumatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/fampra\/14.3.238","volume":"14","author":"Buskila D.","year":"1997","unstructured":"Buskila D.; Neumann L.; Sibirski D.; Shvartzman P.; Awareness of diagnostic and clinical features of fibromyalgia among family physicians. Fam Pract 1997,14(3),238-241","journal-title":"Fam Pract"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"Wolfe F.","year":"2010","unstructured":"Wolfe F.; Clauw D.J.; Fitzcharles M.A.; The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010,62(5),600-610","journal-title":"Arthritis Care Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3899\/jrheum.090368","volume":"36","author":"Choy E.H.","year":"2009","unstructured":"Choy E.H.; Arnold L.M.; Clauw D.J.; Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009,36(10),2330-2334","journal-title":"J Rheumatol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"Wolfe F.","year":"2016","unstructured":"Wolfe F.; Clauw D.J.; Fitzcharles M.A.; 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016,46(3),319-329","journal-title":"Semin Arthritis Rheum"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/426130","volume":"2012","author":"Bellato E.","year":"2012","unstructured":"Bellato E.; Marini E.; Castoldi F.; Fibromyalgia syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012,2012,1-17","journal-title":"Pain Res Treat"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5606\/ArchRheumatol.2015.4801","volume":"30","author":"Altan L.","year":"2015","unstructured":"Altan L.; Sivrioglu Y.; Ercan I.; Can bath ankylosing spondylitis disease activity index be affected by accompanying fibromyalgia or depression? Arch Rheumatol 2015,30(1),34-39","journal-title":"Arch Rheumatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3899\/jrheum.161156","volume":"43","author":"Leung Y.Y.","year":"2016","unstructured":"Leung Y.Y.; Thumboo J.; Fibromyalgia as a contextual factor influencing disease activity measurements in spondyloarthritis and psoriatic arthritis. J Rheumatol 2016,43(11),1953-1955","journal-title":"J Rheumatol"},{"key":"ref=42","first-page":"24","volume":"30","author":"Roussou E.","year":"2012","unstructured":"Roussou E.; Ciurtin C.; Clinical overlap between fibromyalgia tender points and enthesitis sites in patients with spondyloarthritis who present with inflammatory back pain. Clin Exp Rheumatol 2012,30(6)(Suppl. 74),24-30","journal-title":"Clin Exp Rheumatol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00296-007-0344-3","volume":"27","author":"Aloush V.","year":"2007","unstructured":"Aloush V.; Ablin J.N.; Reitblat T.; Caspi D.; Elkayam O.; Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 2007,27(9),865-868","journal-title":"Rheumatol Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4081\/reumatismo.2014.761","volume":"66","author":"Atzeni F.","year":"2014","unstructured":"Atzeni F.; Boccassini L.; Franco M.; Chronic widespread pain in spondyloarthritis. Reumatismo 2014,66(1),28-32","journal-title":"Reumatismo"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3899\/jrheum.110392","volume":"38","author":"Strand V.","year":"2011","unstructured":"Strand V.; Boers M.; Idzerda L.; It\u2019s good to feel better but it\u2019s better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol 2011,38(8),1720-1727","journal-title":"J Rheumatol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397118666220902100151","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208445\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397118666220902100151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T11:53:26Z","timestamp":1685015606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208445\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397118666220902100151","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}